Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor

Background: COVID-19 clinical features include a hypercoagulable state that resembles the antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of antiphospholipid antibodies (aPL). The relationship between aPL-presence and the appearance of thrombi as well as the trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Gil-Etayo, Francisco Javier, Garcinuño, Sara, Lalueza, Antonio, Díaz-Simón, Raquel, García-Reyne, Ana, Pleguezuelo, Daniel Enrique, Cabrera-Marante, Oscar, Rodriguez-Frias, Edgard Alfonso, Perez-Rivilla, Alfredo, Serrano, Manuel, Serrano, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389622/
https://www.ncbi.nlm.nih.gov/pubmed/34440103
http://dx.doi.org/10.3390/biomedicines9080899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389622/
https://www.ncbi.nlm.nih.gov/pubmed/34440103
http://dx.doi.org/10.3390/biomedicines9080899

Ejemplares similares